Psychedellux Archives

Video StaffAugust 13, 2021

This is Psychedellux the week’s top business headline in the psychedelics industry. Compass Pathways plc (Nasdaq: CMPS) reported its financial results for the second quarter of 2021 and gave an update on recent progress across its business. Compass reported a net loss for the three months ending June 2021 was $17.5 million, or $0.44 loss […]

Video StaffJuly 30, 2021

This is Psychedellux – the week’s top business headlines for the psychedelics industry. Field Trip Health Ltd. (OTCQX: FTRPF) has received final approval from The NASDAQ Stock Market to list its common shares on the NASDAQ Global Select Market. The Company’s shares will begin trading at market open on Thursday, July 29, 2021 with the […]

Video StaffJuly 16, 2021

U.S.-based psychedelic investment fund Palo Santo has launched with an initial $35 million in capital raised and an active portfolio of 20 companies. The diversified venture fund said in a statement that it is focused on tackling the growing global mental health crisis by investing in innovative psychedelic-based and adjacent therapies that are poised to shape […]

Video StaffJuly 9, 2021

This is Psychedellux – the week’s top business headlines in the psychedelics industry. Dublin-based GH Research is now listing its stock on the Nasdaq under the symbol “GHRS” after opening for trading on Friday, July 2 at $22. The company had an IPO of 10 million shares at an initial price of $16 per share […]

Video StaffJuly 2, 2021

This is Psychedellux – the weekly recap of the business news in the psychedelics industry. Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) released financial and business highlights for its financial year ended March 31, 2021. The company noted that it had a net loss of $32.2 million for the year ended March 31, 2021 of which non-cash […]

Video StaffJune 25, 2021

Psychedelic biotech company Awakn Life Sciences Corp. (NEO: AWKN) began trading on the NEO Exchange Inc. under the symbol “AWKN”. The company has raised C$13.5 million to date and has plans to open three UK psychedelic-assisted psychotherapy clinics where it will deliver ketamine-assisted therapies near term and MDMA when they secure authorization in 2021. The […]

Video StaffJune 18, 2021

Atai Life Sciences (Nasdaq: ATAI) announced the pricing of its upsized initial public offering in the United States of 15,000,000 common shares at a price to the public of $15.00 per share. atai’s common shares are expected to begin trading on the Nasdaq Global Market on June 18, 2021 under the ticker symbol “ATAI.” In […]

Video StaffJune 4, 2021

Novamind Inc. (CSE:NM)(OTC PINK:NVMDF) reported its fiscal third-quarter results for the three months ending in March. NovaMind reported total revenue of $1.8 million, a 43% quarter-over-quarter, driven by increased patient volume at the Company’s four operating clinics. It has a debt-free balance sheet with $7.6 million in cash and total working capital of $9.9 million […]

Video StaffMay 14, 2021

This is Psychedellux, the week’s top business headlines in the psychedelics industry. COMPASS Pathways plc (Nasdaq: CMPS) reported its financial results for the first quarter of 2021 as the company continues to plug away at research. The net loss was $12.7 million, but Compass was granted 2 patents during the quarter and continues to have […]

Video StaffMay 7, 2021

This is Psychedellux – the leading recap of the week’s top news in the psychedelics industry. The Multidisciplinary Association of Psychedelic Studies (MAPS) released data from its Phase III trial with the FDA for the use of MDMA (ecstasy) to treat PTSD. MDMA showed efficacy for treating PTSD in six MAPS Phase II trials, providing […]

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

In other news

The Daily Hit: January 4, 2024

Connecticut Attorney General Tells Unlicensed Cannabis Events Company to Stop

Testing Concerns Lead to Quarantine for 70% of Mississippi MMJ Goods

Tag: Psychedellux

Psychedellux August 13, 2021

Psychedellux: July 30, 2021

Psychedellux July 16, 2021

Psychedellux: July 9, 2021

Psychedellux July 2, 2021

Psychedellux June 25, 2021

Psychedellux June 18, 2021

Psychedellux June 4, 2021

Psychedellux May 14, 2021

Psychedellux: May 7, 2021

The Daily Hit - TEST TEST TEST

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

Get the latest cannabis news delivered right to your inbox

Get the latest cannabis news delivered right to your inbox